<DOC>
	<DOCNO>NCT02748265</DOCNO>
	<brief_summary>This pilot study new use Epoprostenol via inhalation ( Epoprostenol approve intravenous use ) . The purpose study administer inhaled Epoprostenol intravenous Phenylephrine improve arterial oxygen tension one-lung anesthesia either volatile anesthesia ( Sevoflurane ) intravenous anesthesia ( Propofol ) .</brief_summary>
	<brief_title>Nebulized Epoprostenol ( FLOLAN ) Phenylephrine One Lung Ventilation ( OLV )</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<mesh_term>Tezosentan</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<criteria>Patients undergo esophagectomy via video assist thoracoscopy surgery open thoracotomy . Patients great eighteen year old capacity provide consent . Patients weigh 89kg less . Patients preoperative platelet count &gt; 100,000mm3 Contraindication allergy study drug e.g . epoprostenol , phenylephrine , sevoflurane propofol . Spirometry : Force expiratory Volume ( FEV1 ) less 80 % predicted age . Patients spirometry indicative obstructive lung disease less likely develop hypoxemia OLV compare patient normal spirometry . These patient likely small treatment effect . A history bleed diathesis . Use platelet inhibitor within last seven day e.g . Aspirin , clopidogrel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>